The role of adenovirus in respiratory tract infections

Current Infectious Disease Reports

Volumn 12, Issue 2, 2010, Pages 81-87

  Kunz, Anjali N ^a   Ottolini, Martin ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Acute respiratory disease; Adenovirus; Conjunctivitis; Respiratory tract infections

Indexed keywords

ATTENUATED ADENOVIRUS VACCINE; CIDOFOVIR; IMMUNOGLOBULIN; LIVE VACCINE; UNCLASSIFIED DRUG;

ADENOVIRUS; ADENOVIRUS INFECTION; ARMY; CLINICAL FEATURE; CLINICAL TRIAL; EPIDEMIC; HUMAN; HUMAN ADENOVIRUS INFECTION; KERATOCONJUNCTIVITIS; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PEDIATRICS; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; REVIEW; RNA VIRUS; SEROTYPE; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VIRAL UPPER RESPIRATORY TRACT INFECTION; VIRUS MORPHOLOGY;

EID: 77953543947     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-010-0084-5     Document Type: Review

References (42)

1. Woodward TE: The Armed Forces Epidemiological Board: Its First Fifty Years. Falls Church, VA: Center of Excellence in Military Medical Research and Education, Office of the Surgeon General, Department of the Army; 1994. Available at http://history.amedd.army.mil/booksdocs/itsfirst50yrs/fiftyyears. html.
2. Mandell GL, Bennett JE, Dolin R: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, edn 7. Philadelphia: Elsevier; 2009.
3. Rowe WP, Huebner RJ, Gillmore LK, et al.: Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1953, 84:570-573.
4. Brandt CD, Kim HW, Vargosko AJ, et al.: Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome. Am J Epidemol 1969, 90:484-500.
5. Hale, GA, Heslop HE, Krance RA, et al.: Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999, 23:277-282.
6. Kolavic-Gray SA, Binn LN, Sanchez JL, et al.: Large epidemic of adenovirus type 14 infection among military trainees: Epidemiological, clinical and laboratory studies. Clin Infect Dis 2002, 35:808-818.
7. Van Der Veen J, Dijkman JH: Associations of type 21 Adenovirus with acute respiratory illness in military recruits. Am J Hyg 1962, 76:149-159.
8. Dudding BA, Wagner SC, Zeller JA, et al.: Fatal pneumonia associated with adenovirus type 7 in three military trainees. N Engl J Med 1972, 286:1289-1292.
9. Klinger JR, Sanchez MP, Curtin LA, et al.: Multiple cases of lifethreatening adenovirus pneumonia in a mental health care center. Am J Respir Crit Care Med 1998, 157:645-1549
10. Hakim FA, Tleyjeh IM: Severe adenovirus pneumonia in immunocompetent adults: A case report and review of the literature. Eur J Clin Microbiol Infect Dis 2008, 27:153-158. This article describes severe adenovirus pneumonia with ARDS in immunocompetent adults, which is an unusual clinical presentation.
11. Osamura T, Mizuta R, Yoshika H, et al.: Isolation of adenovirus type 11 from the brain of a neonate with pneumonia and encephalitis. Eur J Pediatr 1993, 152:496-499.
12. Pinto A, Beck R, Jadavji T: Fatal neonatal pneumonia caused by adenovirus type 35. Report of one case and review of the literature. Arch Pathol Lab Med 1992, 116:95-99.
13. Wigger HJ, Blanc WA: Fatal hepatic and bronchial necrosis in adenovirus infection with thymic dysplasia. N Engl J Med 1964, 275:870-874.
14. Leen AM, Rooney CM: Adenovirus as an emerging pathogen in immunocompromised patients. Br J Haematol 2005, 128:135-144.
15. Kojaoghlanian T, Flomenberg P, Horwitz MS: The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 2003, 13:155-171.
16. Krilov LR, Rubin LG, Frogel M, et al.: Disseminated adenovirus infection with hepatic necrosis in patients with HIV and other immunodeficiency states. Rev Infect Dis 1990, 12:303-307.
17. Dingle JH, Langmuir AD: Epidemiology of acute respiratory disease in military recruits. Am Rev Respir Dis 1968, 97 (Suppl):1-65.
18. Top FH, Dudding BA, Russell PK, et al.: Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol 1971, 94:142-146.
19. Metzgar D, Osuna M, Kajon AE, et al.: Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis 2007, 196:1465-1473. This important article details the alarming rise in respiratory tract infections with adenovirus serotypes 4, 7, 14, and 21 in military recruits across the United States.
20. Tate JE, Bunning ML, Lott L, et al.: Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis May 2009, 199:1419-1426. This article focuses on the severity of adenovirus 14 in healthy military recruits, and its importance as an emerging pathogen in this population.
21. Laham FR, Jewell AM, Schoonover AL, et al.: The search for adenovirus 14 in children in Houston, Texas. Pediatr Infect Dis J 2008, 27:653-654.
22. Lewis, PF, Schmidt MA, Lu X, et al.: A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis May 2009, 199:1427-1434. This article describes the clinical presentation and impact of a community outbreak of adenovirus 14.
23. Shields A, Hackman R, Fife K, et al.: Adenovirus infection in patients undergoing bone-marrow transplantation. N Engl J Med 1985, 312:529-533.
24. Flomenberg P, Babbit J, Drobyski W, et al.: Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994, 169:775-781.
25. Aronson B, Aronson S, Sobel G, et al.: Pharyngoconjunctival fevers; report of an epidemic outbreak. AMA J Dis Child 1956, 92:596-612.
26. Bell JA: Clinical manifestation of pharyngoconjunctival fever. Am J Opthalmol 1957, 43:11-14.
27. Chaberny IE, Schnitzler P, Geiss HK, Wendt C: An outbreak of epidemic keratoconjunctivitis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol 2003, 24:514-519.
28. Buffington J, Chapman LE, Stobierski MG, et al.: Epidemic keratoconjunctivitis in a chronic care facility: Risk factors and measures for control. J Am Geriatr Soc 1993, 41:1177-1181.
29. Usui N, Ookoshi H, Mori H, et al.: Clinical features of epidemic keratoconjunctivitis in 41 patients. Nippon Ganka Gakkai Zasshi 2001, 105:183-188.
30. Engelmann I, Madisch I, Pommer H, Heim A: An outbreak of epidemic keratoconjuctivitis caused by a new intermediate adenovirus 22/H8 identified by molecular typing. Clin Infect Dis 2006, 43:e64-e66.
31. Murrah WF: Epidemic keratoconjunctivitis. Ann Ophthalmol 1988, 20:36-38.
32. Damen M, Minnaar R, Glasius P, et al.: Real-time PCR with an internal control for detection of all known human adenovirus serotypes. J Clin Microbiol 2008, 46:3997-4003.
33. Wong S, Pabbaraju K, Pang XL, et al.: Detection of a broad range of human adenoviruses in respiratory tract samples using a sensitive multiplex real-time PCR assay. J Med Virol 2008, 80:856-865. This article shows the utility and sensitivity of realtime PCR in detecting most clinically relevant adenovirus serotypes.
34. Metzgar D, Skochko G, Gibbins C, et al.: Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples. PLoS One 2009, 4:e7081.
35. Bruno B, Gooley T, Hackman RC, et al.: Adenovirus infection in hematopoietic stem cell transplantation: Effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant 2003, 9:341-352.
36. Legrand F, Berrebi D, Houhou N, et al: Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 2001, 27:621-626.
37. Saquib R, Melton LB, Chandrakantan A, et al.: Disseminated adenovirus infection in renal transplant recipients: The role of cidofovir and intravenous immunoglobulin. Transpl Infect Dis 2009 (Epub ahead of print).
38. Lessler J, Reich NG, Brookmeyer R, et al.: Incubation periods of acute respiratory viral infections: A systemic review. Lancet Infect Dis 2009, 9:291-300.
39. Russell KL, Hawksworth AW, Ryan MAK, et al.: Vaccinepreventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 2006, 24:2835-2842.
40. Hilleman MR: Efficacy of and indications for use of adenovirus vaccine. Am J Public Health Nations Health 1958, 48:153-158.
41. Kolavic-Gray SA, Binn LN, Sanchez JL, et al: Large epidemic of adenovirus type 4 infection among military trainees: Epidemiological, clinical and laboratory studies. Clin Infect Dis 2002, 35:808-818.
42. Lyons A, Longfield J, Kuschner R, et al.: A double-blinded, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine 2008, 26:2890-2898. This article discusses the results of the new live, oral adenovirus vaccines during their phase 1 clinical trials.